Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.
Peter NashAndreas KerschbaumerThomas DörnerMaxime DougadosRoy M FleischmannKlaus GeisslerIain McInnesJanet E PopeDésirée Mfm van der HeijdeMichaela Stoffer-MarxTsutomu TakeuchiMichael TraunerKevin L WinthropMaarten P T de WitDaniel AletahaXenofon BaraliakosWolf-Henning BoehnckePaul EmeryJohn D IsaacsJoel KremerEun Bong LeeWalter P MaksymowychMarieke VoshaarLai-Shan TamYoshiya TanakaFilip van den BoschRené WesthovensRicardo XavierJosef S SmolenPublished in: Annals of the rheumatic diseases (2020)
The consensus provides an assessment of evidence for efficacy and safety of an important therapeutic class with guidance on issues of practical management.
Keyphrases